SMS PHARMACEUTICALS LTD. - 532815 - Financial Results For The First Quarter Ended 30Th June, 2023
Financial Results for the quarter ended 30th June, 202308-08-2023
08-08-2023
SMS PHARMACEUTICALS LTD. - 532815 - Board Meeting Outcome for Outcome Of Board Meeting And Financial Results
Outcome of Board Meeting and Financial Results08-08-2023
SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Investor's Conference Call05-08-2023
SMS PHARMACEUTICALS LTD. - 532815 - Board Meeting Intimation for Approval Of Un-Audited Financial Results (Standalone & Consolidated) For The First Quarter Ended 30Th June, 2023.
SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2023 ,inter alia, to consider and approve un-audited Financial Results (Standalone & Consolidated) for the First Quarter ended 30th June, 2023.01-08-2023
SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of copies of Newspaper Publication- Notice regarding transfer of shares to IEPF19-07-2023
SMS PHARMACEUTICALS LTD. - 532815 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg.74(5) of SEBI(DP)Regulations, 201811-07-2023
SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication- Notice of Postal Ballot11-07-2023
SMS PHARMACEUTICALS LTD. - 532815 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Submission of Notice of Postal Ballot10-07-2023
SMS PHARMACEUTICALS LTD. - 532815 - Closure of Trading Window
Intimation of Closure of Trading Window28-06-2023
SMS PHARMACEUTICALS LTD. - 532815 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for TVT Infracon LLP21-06-2023